Form 4: Quaker Chemical Corp Executive Fleck Reports Stock Transactions
SEC Form 4 Filing
Jeffrey L. Fleck, SVP and Chief GSCO of Quaker Chemical Corp, reports transactions involving common stock and restricted stock units.
Summary
- On March 15, 2025, Jeffrey L. Fleck, SVP, Chief GSCO of Quaker Chemical Corp, reported transactions related to the company's common stock.
- Fleck surrendered 89 shares to cover withholding tax obligations at a price of $128.47 per share related to restricted stock units granted on March 15, 2023.
- He also surrendered 81 shares to cover withholding tax obligations at a price of $128.47 per share related to restricted stock units granted on March 15, 2024.
- 266 restricted stock units were converted into common stock.
- Dividend equivalent rights were settled for 3 shares.
- Fleck was granted 1,245 time-based restricted stock units that vest in three annual installments beginning March 15, 2026.
- Following these transactions, Fleck directly owns 2,426 shares of common stock and 1,245 restricted stock units.
Sentiment
Score: 6
Explanation: The document reflects routine insider transactions related to compensation. It's neutral from an investment perspective.
Positives
- The granting of 1,245 restricted stock units to Mr. Fleck indicates a continued investment in his role and future with the company.
Future Outlook
The document details future vesting of restricted stock units, indicating continued equity-based compensation for the reporting person.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates normal compensation practices.
Comparison to Industry Standards
- Equity compensation is a standard practice across publicly traded companies, particularly for senior management.
- The vesting schedules and types of equity awards (restricted stock units) are typical for companies of Quaker Chemical's size and industry.
- Similar companies such as Lubrizol, BASF, and Evonik offer comparable equity-based compensation packages to their executives.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they primarily reflect internal compensation adjustments.
Key Dates
| Date | Description |
|---|---|
| 03/15/2023 | Date of original restricted stock grant related to tax obligation. |
| 03/15/2024 | Date of original restricted stock grant related to tax obligation and vesting of 799 time-based restricted stock units. |
| 03/15/2025 | Date of reported transactions: stock surrender for tax obligations, conversion of restricted stock units, and settlement of dividend equivalent rights. |
| 03/15/2026 | Start date for the three annual installments of vesting for the 1,245 restricted stock units granted on March 15, 2025. |
| 03/18/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.